Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens
- 31 January 2014
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 74 (6), 680-687
- https://doi.org/10.1002/pros.22786
Abstract
BACKGROUND Intraductal carcinoma of the prostate (IDC-P) is an adverse prognostic factor for radical prostatectomy (RP). The endpoint in most IDC-P studies is increased prostate-specific antigen (PSA) levels. The aim of this study was to evaluate whether IDC-P in RP specimens is an adverse prognostic factor for progression-free survival (PFS) and cancer-specific survival (CSS). METHODS We retrospectively evaluated 206 high-risk prostate cancer patients treated with RP and analyzed data on age, serum PSA level at diagnosis, biopsy Gleason score (bGS), surgical margin (SM), clinical T stage (cT), extraprostatic extension (EPE), seminal vesicle invasion (SVI), lymph node metastasis (LN), and neoadjuvant therapy. RESULTS An IDC-P component was found in 104 cases. Forty-four patients experienced clinical failure, and 20 patients died of the disease. Patients with IDC-P showed a higher bGS and stage (including cT, EPE, SVI, and LN) than those without IDC-P. In univariate analysis, IDC-P, PSA level, bGS, SM, cT, SVI, LN, and EPE (P < 0.0001) were significantly associated with PFS. IDC-P (P = 0.0004), PSA level (P < 0.0001), SM (P = 0.0013), cT (P = 0.0019), SVI (P = 0.0012), and LN (P = 0.0002) were significantly associated with CSS. In multivariate analysis, IDC-P (P = 0.0038), and cT (P = 0.0001) were significantly associated with PFS. IDC-P (P = 0.0238) and PSA level (P = 0.0112) were significantly associated with CSS. CONCLUSIONS IDC-P in RP specimens was an independent risk factor for PFS and CSS and could predict clinical outcomes. Prostate 74:680–687, 2014.Keywords
This publication has 29 references indexed in Scilit:
- Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)The Lancet, 2012
- Prognostic value of the CAPRA clinical prediction rule: a systematic review and meta-analysisBJU International, 2012
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2011
- A Nomogram Predicting Prostate Cancer-Specific Mortality after Radical ProstatectomyUrologia Internationalis, 2010
- Prostate-Specific Antigen (PSA) as a Surrogate End Point for Survival in Prostate Cancer Clinical TrialsEuropean Urology, 2008
- Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancerHuman Pathology, 1998
- Cribriform Carcinoma of the Prostate and Cribriform Prostatic Intraepithelial NeoplasiaThe American Journal of Surgical Pathology, 1998
- Spread of Adenocarcinoma Within Prostatic Ducts and AciniThe American Journal of Surgical Pathology, 1996
- The Incidence of Prostate Cancer Progression with Undetectable Serum Prostate Specific Antigen in a Series of 394 Radical ProstatectomiesJournal of Urology, 1995
- Ductal spread in prostatic carcinomaCancer, 1985